A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA

Publication

Pediatric blood & cancer

Publication ID (Profile URL)

https://researcherprofiles.org/profile/30700055

Publication Year

2018

PubMed ID

30378256

Publication Title

Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2019 02; 66(2):e27524.